Litigation
May 28, 2011
Amylin Wins TRO Against Eli Lilly
Amylin Pharmaceuticals Inc. won a temporary restraining order against Eli Lilly and Co. in federal court on Wednesday that prevents confidential information about its diabetes drug from getting into the hands of a direct competitor.
Daily Journal Staff Writer
Amylin Pharmaceuticals Inc. won a temporary restraining order in federal court on Wednesday that prevents confidential information about its diabetes drug from getting into the hands of a direct competitor.
San Diego U.S. District Judge Janis L. Sammartino ruled that Amylin was likely to succeed on its claim that defendant Eli Lilly and Co., Amylin's partner in marketing Amylin's drug Byetta...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In